Search research articles
Contact Us
Filters
Showing results (221-230 of 336) with videos related to
Page
of 34
Sort By:
Psychology Research and Behavior Management
|
December 24, 2021
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management"
Kenneth Blum, Bruce Steinberg, Marjorie C Gondre-Lewis, et al.
Acta Scientific Neurology
|
August 29, 2025
Theorizing The Role of Gama Type Endorphins in Schizophrenia and Alcoholism: Promoting Genetic Testing and Attempts at Inducing "Dopamine Homeostasis"
Kenneth Blum, Kai Uwe Lewandowski, Alireza Sharafshah, et al.
Medical Hypotheses
|
October 31, 2006
Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS)
Kenneth Blum, Thomas J H Chen, Brian Meshkin, et al.
Plos One
|
April 27, 2017
Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z
Marcelo Febo, Kenneth Blum, Rajendra D Badgaiyan, et al.
Journal of Integrative Neuroscience
|
July 4, 2025
Exercise Leads to Brain Glucose Metabolism Activation, Increased Dopamine D1 Receptor Levels and is Negatively Correlated with Social Behavior
Michael Bobick, Colin Hanna, John Tyler, et al.
INNOSC Theranostics & Pharmacological Sciences
|
August 9, 2024
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence
Mark S Gold, Kenneth Blum, Abdalla Bowirrat, et al.
Biomedicines
|
April 23, 2022
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Marjorie C Gondré-Lewis, Igor Elman, Tanya Alim, et al.
Biomedical Journal of Scientific & Technical Research
|
October 30, 2018
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis
Kenneth Blum, Edward J Modestino, Jennifer Neary, et al.
Acta Scientific Neurology
|
August 9, 2024
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
Edward J Modestino, Abdalla Bowirrat, Kai-Uwe Lewandrowski, et al.
Open Journal of Immunology
|
November 21, 2022
Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of "Dopamine Homeostasis"
Kenneth Blum, Catherine A Dennen, Eric R Braverman, et al.
Page
of 34
Search research articles
Search
Showing results (221-230 of 336) with videos related to
Sort By:
Page
of 34
Psychology Research and Behavior Management
|
December 24, 2021
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management"
Kenneth Blum, Bruce Steinberg, Marjorie C Gondre-Lewis, et al.
Acta Scientific Neurology
|
August 29, 2025
Theorizing The Role of Gama Type Endorphins in Schizophrenia and Alcoholism: Promoting Genetic Testing and Attempts at Inducing "Dopamine Homeostasis"
Kenneth Blum, Kai Uwe Lewandowski, Alireza Sharafshah, et al.
Medical Hypotheses
|
October 31, 2006
Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS)
Kenneth Blum, Thomas J H Chen, Brian Meshkin, et al.
Plos One
|
April 27, 2017
Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z
Marcelo Febo, Kenneth Blum, Rajendra D Badgaiyan, et al.
Journal of Integrative Neuroscience
|
July 4, 2025
Exercise Leads to Brain Glucose Metabolism Activation, Increased Dopamine D1 Receptor Levels and is Negatively Correlated with Social Behavior
Michael Bobick, Colin Hanna, John Tyler, et al.
INNOSC Theranostics & Pharmacological Sciences
|
August 9, 2024
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence
Mark S Gold, Kenneth Blum, Abdalla Bowirrat, et al.
Biomedicines
|
April 23, 2022
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Marjorie C Gondré-Lewis, Igor Elman, Tanya Alim, et al.
Biomedical Journal of Scientific & Technical Research
|
October 30, 2018
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis
Kenneth Blum, Edward J Modestino, Jennifer Neary, et al.
Acta Scientific Neurology
|
August 9, 2024
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
Edward J Modestino, Abdalla Bowirrat, Kai-Uwe Lewandrowski, et al.
Open Journal of Immunology
|
November 21, 2022
Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of "Dopamine Homeostasis"
Kenneth Blum, Catherine A Dennen, Eric R Braverman, et al.
Page
of 34